Overall, the available evidence suggests that μg, through the inhibition of adhesion and growth pathways (e.g., FAK, RhoA, YAP1, Cyclin D), cytoskeletal remodeling, and modulation of apoptosis/survival regulators, exerts a time- and cell type-dependent suppressive effect on tumor proliferation. The gene discussed is RHOA; the disease is neoplasm.